NEW YORK (GenomeWeb) – Illumina today announced that its startup accelerator has secured $40 million from Viking Global Investors to fund promising genomic firms.

Accelerator graduates that raise between $1 million and $5 million in new capital will receive additional dollar-for-dollar match funding from Illumina Accelerator Boost Capital.

"This capital commitment will be instrumental in driving value for our startups as they advance breakthrough applications in genomics," Amanda Cashin, head of Illumina Accelerator, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.